Pulmatrix (NASDAQ:PULM – Get Rating) announced its earnings results on Friday. The biotechnology company reported ($1.22) EPS for the quarter, reports. The business had revenue of $1.50 million during the quarter. Pulmatrix had a negative net margin of 310.26% and a negative return on equity of 51.32%. Pulmatrix Stock Performance PULM traded down $0.14 during […]